Biofabri is a Spanish biopharmaceutical company founded in 2008 based on a legacy of more than 70 years' experience in the pharmaceutical industry. Its main activity focuses on the research&development and industrial production of vaccines for human use and the contract manufacturing and distribution (CDMO) of pharmaceutical products.
Our most advanced project is a vaccine against Tuberculosis (at phase Ib), that is being developed in collaboration with the University of Zaragoza, Pasteur Institute and TB Vaccine Initiative. We count with a valuable infrastructure and knowledge to address biotech projects from a laboratory stage to a large scale production.
Biofabri is a company of Zendal group, a bioparmecutical group focsed on vaccines and biotechnology.
Company Details
- Employees
- 17
- Founded
- -
- Address
- La Relva S/n, 1,spain
- Phone
- 34 986 34 52 00
- bi****@****bri.com
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- biofabri.com
- Keywords
- Biotechnology and Pharmacy, Helping to other companies to progress from lab bench to production, For a healthier world.
- HQ
- PORRIÑO, Pontevedra
Biofabri Questions
Biofabri's helpline number is 34 986 34 52 00
Biofabri's website is biofabri.com
Biofabri's LinkedIn profile is https://es.linkedin.com/company/biofabri
Biofabri has
17 employees.
View email and phone details for 17
employees at Biofabri.
Biofabri's industry is
Pharmaceutical Manufacturing
Biofabri's top competitors are
Galchimia,
Cz Vaccines,
Bioga,
Pharmamar,
Zinereo Pharma,
Zendal,
Lonza,
Hifas Da Terra S.l.,
Amslab,
Ceamsa.
Biofabri's support email address is biofabri@biofabri.com
Biofabri's categories are Pharmaceutical Manufacturing
Biofabri's founding year is 2008
